Prepared by:
University of California, San Francisco-Stanford University
Evidence-based Practice Center, Stanford, CA
Principal Investigator
Deborah Grady, M.D., M.P.H.
EPC Coordinator
Kathryn McDonald, M.M.
EPC Staff
Kara Bischoff
Aurelie Cabou
Christopher Gehrman
Kate Hoerster
Lily Chaput, M.D., M.P.H.
Margaret Kristof, M.S., R.N.
Kathryn Melsop, M.S.
Dan H. Moore, Ph.D.
Topic Team Staff
Noninvasive Diagnostic Tests
Mary Beattie, M.D.
Louise Metz, M.D.
Kirsten Fleishmann, M.D.
Rita Redberg, M.D.
Lipid Lowering Treatment
Judith Walsh, M.D., M.P.H.
Michael Pignone, M.D., M.P.H.
Paul Varosy, M.D.
Diabetes as Risk Factor
Alka Kanaya, M.D.
Lily Chaput, M.D., M.P.H.
Troponins
Paul Heindenreich, M.D.
Kathy McDonald, M.M.
UCSF/Mt. Zion Fishbon Library Staff
Gail Sorrough, M.L.I.S.
Gloria Won, M.L.I.S.
File Name Description Software Version File Size ________________________________________________________________________________________________ 01front.doc Microsoft Word® Document MS Word® 2002 49KB 7 pages Contents: Title Page, Preface, Structured Abstract ________________________________________________________________________________________________ 02conts.doc Microsoft Word® Document MS Word® 2002 37KB 4 pages Contents: Table of Contents ________________________________________________________________________________________________ 03summ.doc Microsoft Word® Document MS Word® 2002 51KB 7 pages Contents: Summary: Overview, Key Questions, Methodology, Findings, Future Research ________________________________________________________________________________________________ 04chap1.doc Microsoft Word® Document MS Word® 2002 37KB 6 pages Contents: Chapter 1. Introduction: Organization, Key Questions, References for Introduction ________________________________________________________________________________________________ 05chap2.doc Microsoft Word® Document MS Word® 2002 119KB 17 pages Contents: Chapter 2. Systematic Review of the Accuracy of Exercise Myocardial Perfusion Imaging and Echocardiography for Diagnosis of Coronary Heart Disease in Women: Introduction, Methodology, Results, Conclusions, Future Research, References ________________________________________________________________________________________________ 06chap3.doc Microsoft Word® Document MS Word® 2002 455KB 15 pages Contents: Chapter 3. Systematic Review of Lipid Lowering Treatment to Reduce Risk of Coronary Heart Disease in Women: Introduction, Methodology, Results, Conclusions, Future Research, References ________________________________________________________________________________________________ 07chap4.doc Microsoft Word® Document MS Word® 2002 125KB 16 pages Contents: Chapter 4. Systematic Review of Diabetes as a Risk Factor for Coronary Heart Disease in Women: Introduction, Methodology, Results, Conclusions, Future Research, References ________________________________________________________________________________________________ 08chap5.doc Microsoft Word® Document MS Word® 2002 812KB 21 pages Contents: Chapter 5. Systematic Review of Troponin as a Prognostic Factor for CHD in Women: Introduction, Methodology, Results, Conclusions, Future Research, References Figure 1. Troponin: Death for women with and without an elevated troponin Figure 2. Troponin: Death for men with and without an elevated troponin Figure 3. Troponin: Death or myocardial infarction for women with and without an elevated troponin Figure 4. Troponin: Death or myocardial infarction for men with and without an elevated troponin Figure 5. Troponin: Nonfatal infarction for women with and without an elevated troponin Figure 6. Troponin: Nonfatal infarction for men with and without an elevated troponin Figure 7. Troponin: Odds ratios and their summary for death for both men and women Figure 8. Troponin: Odds ratios and their summary for death or myocardial infarction for both men and women Figure 9. Troponin: Odds ratios and their summary for nonfatal myocardial infarction for both men and women ________________________________________________________________________________________________ 09etbls.doc Microsoft Word® Document MS Word® 2002 814KB 19 pages Contents: Evidence Table 1. Diagnostic Testing: Characteristics of studies of exercise myocardial perfusion imaging Evidence Table 2. Diagnostic Testing: Characteristics of studies of exercise echocardiography Evidence Table 3. Diagnostic Testing: Findings of exercise myocardial perfusion imaging and summary estimates of accuracy Evidence Table 4. Diagnostic Testing: Summary estimates of accuracy of myocardial perfusion imaging from studies using sestamibi compared to studies using thallium Evidence Table 5. Diagnostic Testing: Findings of studies of exercise echocardiography and summary estimates of accuracy Evidence Table 6. Lipids: Characteristics of included trials Evidence Table 7. Lipids: Outcomes of eligible studies Evidence Table 8. Lipids: Summary results Evidence Table 9. Diabetes: Characteristics of studies of coronary heart disease risk in diabetics vs. nondiabetics Evidence Table 10. Diabetes: Adjusted odds ratios for CHD mortality, nonfatal MI, and all-cause mortality by sex Evidence Table 11. Diabetes: Summary odds ratios for CHD mortality, nonfatal myocardial infarction, and all-cause mortality by sex Evidence Table 12. Diabetes: Summary odds ratios for CHD mortality by sex, quality of studies and sensitivity analysis Evidence Table 13. Troponin: Characteristics of the study population by gender Evidence Table 14. Troponin: Characteristics of the study reports Evidence Table 15. Troponin: Outcomes for women Evidence Table 16. Troponin: Outcomes for men ________________________________________________________________________________________________ 10biblio.doc Microsoft Word® Document MS Word® 2002 81KB 14 pages Contents: Bibliography ________________________________________________________________________________________________ 11appa.doc Microsoft Word® Document MS Word® 2002 32KB 3 pages Contents: Appendix A. Peer Reviewers ________________________________________________________________________________________________ 12appb.doc Microsoft Word® Document MS Word® 2002 94KB 5 pages Contents: Appendix B. Quality Evaluation Forms ________________________________________________________________________________________________ 13appc.doc Microsoft Word® Document MS Word® 2002 237KB 20 pages Contents: Appendix C. Data Abstraction Forms ________________________________________________________________________________________________ 14appd.doc Microsoft Word® Document MS Word® 2002 48KB 4 pages Contents: Appendix D. Abbreviations and Acronyms ________________________________________________________________________________________________
AHRQ Publication No. 03-E037
Current as of May 2003
Internet Citation:
Diagnosis and Treatment of Coronary Heart Disease in Women: Systematic Reviews of Evidence on Selected Topics. File Inventory, Evidence Report/Technology Assessment Number 81. AHRQ Publication No. 03-E037, May 2003. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/clinic/chwom2inv.htm
Return to Evidence-based Practice
Clinical Information
AHRQ Home Page
Department of Health and Human Services